Pure Global's Guide to UAE MedTech Market Access: Why Your Authorized Representative is the Key to Success episode artwork

EPISODE · Sep 10, 2025 · 3 MIN

Pure Global's Guide to UAE MedTech Market Access: Why Your Authorized Representative is the Key to Success

from MedTech Global Insights

The United Arab Emirates is a prime market for MedTech expansion, but entry is guarded by a critical gatekeeper: the Local Authorized Representative. This role is far more than a simple administrative requirement; it is a legal necessity that holds significant sway over a manufacturer's success and compliance. This episode of MedTech Global Insights explores the essential functions, legal responsibilities, and strategic importance of the UAE Authorized Representative. We uncover the day-to-day duties of a representative, from managing initial MOHAP registration to handling critical post-market surveillance and vigilance reporting. We also dissect the common but risky practice of appointing a distributor for this role and explain how this can jeopardize your market access and create long-term complications. Consider this scenario: A European MedTech company appoints its UAE distributor as its Authorized Representative to save on costs. A year later, they decide to switch to a new, more effective distributor. However, they discover the product registration is legally held by the original distributor, who is now unwilling to transfer it without a substantial fee. The company is now trapped: either pay the exorbitant fee or pull their product from the market and start the entire costly registration process over with a new representative, losing over a year of sales and market presence. Key Takeaways: - Is appointing your distributor as your legal representative a strategic shortcut or a long-term liability? - What are the specific legal responsibilities your company is delegating to your UAE representative? - How can the wrong representative choice lead to a complete loss of market access during a distributor change? - What are the key differences in post-market vigilance requirements between the EU and the UAE that your representative must know? - How do you verify if a potential representative has the expertise to handle complex interactions with MOHAP? - Why is an independent representative crucial for maintaining control over your product registration and intellectual property? - What happens if your representative fails to properly report an adverse event to the authorities? For more information, contact us at [email protected] or visit https://pureglobal.com/.

Episode metadata supplied by the publisher feed · Published Sep 10, 2025

Embed this episode

NOW PLAYING

Pure Global's Guide to UAE MedTech Market Access: Why Your Authorized Representative is the Key to Success

0:00 3:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MedTech Global Insights?

This episode is 3 minutes long.

When was this MedTech Global Insights episode published?

This episode was published on September 10, 2025.

Can I download this MedTech Global Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!